Analysts expect Evogene Ltd. to report revenue of 419,352.00 for Q3 26, against a range of 398,493.43 to 440,210.57. The most recent reported quarter, Q2 26, came in at 347,000.00, a 10.6% beat against the 313,737.12 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.80 M | 1.61 M | 2.44 M | 884,000.00 | 312,000.00 | 314,000.00 | 334,000.00 | 347,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.86 M | 3.68 M | 4.96 M | 1.03 M | 725,786.21 | 298,771.38 | 372,115.67 | 330,264.79 | 440,210.57 | 433,969.14 | 672,963.13 | 535,694.43 | 668,314.27 | 831,928.59 | 1.46 M | 1.06 M | ||||||||||
| Low Estimate | 2.68 M | 3.08 M | 4.28 M | 951,910.76 | 605,413.79 | 276,457.12 | 313,502.83 | 297,209.45 | 398,493.43 | 367,049.62 | 553,048.19 | 498,934.07 | 548,211.55 | 759,638.05 | 1.33 M | 880,398.43 | ||||||||||
| Consensus Estimate | 2.77 M | 3.38 M | 4.62 M | 990,161.70 | 665,600.00 | 287,614.25 | 342,809.25 | 313,737.12 | 419,352.00 | 400,509.38 | 613,005.66 | 517,314.25 | 608,262.91 | 795,783.32 | 1.39 M | 972,675.15 |
Analysts expect Evogene Ltd. to report earnings per share of -0.29 for Q3 26, against a range of -0.31 to -0.27. The most recent reported quarter, Q2 26, came in at -0.14, a 46.2% beat against the -0.26 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.31 | 0.06 | -0.38 | -0.50 | 0.44 | -0.61 | -0.60 | -0.14 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.90 | -0.73 | -0.46 | -0.63 | -0.40 | -0.23 | -0.25 | -0.24 | -0.27 | -0.23 | -0.54 | -0.14 | 0.07 | -0.10 | -0.57 | -0.18 | ||||||||||
| Low Estimate | -1.00 | -0.79 | -0.52 | -0.69 | -0.44 | -0.27 | -0.27 | -0.28 | -0.31 | -0.27 | -0.62 | -0.18 | 0.07 | -0.12 | -0.67 | -0.22 | ||||||||||
| Consensus Estimate | -0.95 | -0.76 | -0.49 | -0.66 | -0.42 | -0.25 | -0.26 | -0.26 | -0.29 | -0.25 | -0.58 | -0.16 | 0.07 | -0.11 | -0.62 | -0.20 |
Pull Wall Street consensus for Evogene Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=EVGN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "EVGN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=EVGN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();